Clinical Trials Logo

Clinical Trial Summary

The aim of the study was to intervene in the Aerobic exercise time of patients with STEMI and to explore the optimal exercise time for STEMI patients


Clinical Trial Description

Cardiovascular disease (CVD) remains the first cause of mortality worldwide. More than 30% of CVD-connected fatalities are ascribed to ST-segment Elevation myocardial infarction (STEMI). There is strong and consistent evidence that aerobic exercise after a STEMI improves overall and cardiovascular-related mortality. Aerobic exercise (AE) acts in key mechanisms of cardiac remodeling and function improvement after STEMI, thus contributing both to prevent or postpone harmful adaptations, and even to recover from negative alterations caused by cardiac ischemia. However, the time of day to exercise for STEMI patients' optimal cardiac benefits is currently unknown. The circadian clock endows the host with temporal precision and robust adaptation to the surrounding environment. Almost all physiologic, metabolic and endocrine processes, including glycolysis, lipid and carbohydrate metabolism as well as cardiovascular function (heart rate, blood pressure) are influenced by the circadian clock. Recent investigations in rodents utilizing gain-of-function/loss-of-function models and in humans have identified Adverse cardiovascular events have day/night patterns is related to endogenous circadian clock control of platelet activation events. Several studies have also demonstrated the effect of AE at different times on blood pressure. Indeed, timing is critical in amplifying the beneficial impact of AE. However, these studies did not address cardiac structural remodeling or other CVD-related metabolic markers, it difficult to determine the physiological and structural effects of different time AE on cardiovascular health. Thus, In this trial our aim is to assess, in patients who have had an STEMI, AE in which time of a day can give the best benefits to cardiac remodeling and function improvement. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06385834
Study type Interventional
Source RenJi Hospital
Contact Jun PU, MD
Phone 13817577592
Email pujun310@hotmail.com
Status Not yet recruiting
Phase N/A
Start date April 30, 2024
Completion date July 30, 2028

See also
  Status Clinical Trial Phase
Recruiting NCT04962178 - Evaluate Early Invasive Strategy for Patients With STEMI Presenting 24-48 Hours From Symptom Onset N/A
Not yet recruiting NCT04549766 - Predictive Value of PRECISE DAPT Score in STEMI Patients After Primary PCI
Not yet recruiting NCT05511831 - The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMI Phase 4
Completed NCT05649696 - Prolonged Clinical Follow-up of OPTIMA-5 Phase 4
Recruiting NCT05506449 - The RECOVER IV Trial N/A
Completed NCT01144819 - Platelet Inhibition in the Acute Phase of STEMI N/A
Recruiting NCT03539133 - Systemic Organ Communication in STEMI
Completed NCT01642667 - Pharmacoinvasive Therapy With Prourokinase Phase 2/Phase 3
Completed NCT04131816 - HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program N/A
Recruiting NCT03768453 - EARLY-MYO-CMR Registry
Completed NCT04942977 - Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy N/A
Recruiting NCT04912518 - Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction N/A
Completed NCT04996901 - The Chinese STEMI PPCI Registry (CSPR)
Recruiting NCT05892042 - Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction N/A
Completed NCT02197117 - Effect of Remote Ischemic Conditioning in Heart Attack Patients N/A
Completed NCT02733341 - The Effect of IV Cangrelor and Oral Ticagrelor Study Phase 4
Not yet recruiting NCT04110691 - Impact of Stent Length and Diameter on Patients Undergoing Primary PCI
Recruiting NCT05510661 - Use of Export in Primary Percutaneous Coronary Intervention N/A
Recruiting NCT05709626 - PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction Phase 4
Recruiting NCT05046483 - Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI